Evidence map›Paper›PMID 36014600›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Dependence of Quantum Dot Toxicity In Vitro on Their Size, Chemical Composition, and Surface Charge.

Alyona Sukhanova, Svetlana Bozrova, Evgeniia Gerasimovich, Maria Baryshnikova, Zinaida Sokolova, Pavel Samokhvalov, Chris Guhrenz, Nikolai Gaponik, Alexander Karaulov, Igor Nabiev

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Alyona SukhanovaLaboratoire de Recherche en Nanosciences, LRN-EA4682, Université de Reims Champagne-Ardenne, 51100 Reims, France.ORCID 0000-0003-2796-7898
Svetlana BozrovaLaboratory of Nano-Bioengineering, National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.
Evgeniia GerasimovichLaboratoire de Recherche en Nanosciences, LRN-EA4682, Université de Reims Champagne-Ardenne, 51100 Reims, France.ORCID 0000-0002-9433-2246
Maria BaryshnikovaLaboratory of Experimental Diagnostics and Biotherapy of Tumors, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russian Federation, 115478 Moscow, Russia.
Zinaida SokolovaLaboratory of Experimental Diagnostics and Biotherapy of Tumors, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russian Federation, 115478 Moscow, Russia.
Pavel SamokhvalovLaboratory of Nano-Bioengineering, National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.ORCID 0000-0002-2878-8376
Chris GuhrenzPhysical Chemistry, Technische Universität Dresden, Zellescher Weg 19, 01069 Dresden, Germany.
Nikolai GaponikPhysical Chemistry, Technische Universität Dresden, Zellescher Weg 19, 01069 Dresden, Germany.
Alexander KaraulovDepartment of Clinical Immunology and Allergology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University (Sechenov University), 119146 Moscow, Russia.ORCID 0000-0002-1930-5424
Igor NabievLaboratoire de Recherche en Nanosciences, LRN-EA4682, Université de Reims Champagne-Ardenne, 51100 Reims, France.ORCID 0000-0002-8391-040X
Laboratoire de Recherche en NanosciencesMinistry of Health of the Russian Federation · RUNational Research Nuclear University MEPhI · RUSechenov University · RUTechnische Universität Dresden · DE

Funding

Agence Nationale de la Recherche ANR-20-CE19-009-02Ministry of Science and Higher Education of the Russian Federation 075-15-2021-937 (NanoToBio project).
6 · The paper itself

Abstract

Semiconductor nanocrystals known as quantum dots (QDs) are of great interest for researchers and have potential use in various applications in biomedicine, such as in vitro diagnostics, molecular tracking, in vivo imaging, and drug delivery. Systematic analysis of potential hazardous effects of QDs is necessary to ensure their safe use. In this study, we obtained water-soluble core/shell QDs differing in size, surface charge, and chemical composition of the core. All the synthesized QDs were modified with polyethylene glycol derivatives to obtain outer organic shells protecting them from degradation. The physical and chemical parameters were fully characterized. In vitro cytotoxicity of the QDs was estimated in both normal and tumor cell lines. We demonstrated that QDs with the smallest size had the highest in vitro cytotoxicity. The most toxic QDs were characterized by a low negative surface charge, while positively charged QDs were less cytotoxic, and QDs with a greater negative charge were the least toxic. In contrast, the chemical composition of the QD core did not noticeably affect the cytotoxicity in vitro. This study provides a better understanding of the influence of the QD parameters on their cytotoxicity and can be used to improve the design of QDs.

Indexed as

cytotoxicitynanomaterial biological interactionsnanotoxicityquantum dotssemiconductor nanocrystals

Identifiers

PMID36014600
PMCPMC9416395
OpenAlexW4291377336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.